Xin Li | Sports Medicine | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Xin Li | Sports Medicine | Best Researcher Award

Associate Professor| Tianjin Normal University | China

Dr. Xin Li is an accomplished scholar and educator specializing in clinical medicine and sports health sciences, currently serving as an Associate Professor at Tianjin Normal University since 2006. She obtained her Doctor of Medicine (MD) in Clinical Medicine from Tianjin Medical University in July 2006. Over nearly two decades of academic and research experience, Dr. Li has established herself as a leading expert at the intersection of clinical medicine, exercise science, and health management. Her teaching portfolio encompasses a range of courses in sports health, exercise rehabilitation, and health management, with a focus on integrating clinical case studies into theoretical instruction to enhance students’ practical competencies and professional insight. Dr. Li’s research primarily addresses exercise interventions for chronic diseases, sports injury prevention, and rehabilitation science, contributing to the growing evidence base linking physical activity with disease prevention and functional recovery. She has led and participated in numerous provincial and municipal research projects, achieving notable outcomes that have advanced the application of medical principles in sports health practice. To date, Dr. Li has published over ten academic papers in peer-reviewed core journals and international conferences, several of which have been widely cited and recognized within the academic community for their methodological rigor and clinical relevance. Her collaborative approach bridges disciplines such as physiology, public health, and kinesiology, fostering innovation and interdisciplinary integration in sports medicine research. Beyond academia, Dr. Li’s work holds significant societal impact, promoting the scientific development of exercise-based health strategies for chronic disease management and population well-being. Combining solid clinical expertise, pedagogical excellence, and a strong research record, Dr. Xin Li continues to contribute meaningfully to the advancement of sports health education and evidence-based medical practice in China and beyond.

Profile: Scopus 

Featured Publications

Li, X. (2025). The influence of initial and final character positional probabilities on the flexibility of position coding in two-character word identification. Acta Psychologica Sinica.

Dr. Xin Li’s work bridges clinical medicine and sports science, advancing evidence-based approaches to exercise intervention, chronic disease prevention, and rehabilitation. Her research and teaching contribute to improving public health outcomes and enhancing human performance, promoting global innovation in integrated medical and sports health education.

Probal Banerjee | Cancer Biology | Best Researcher Award

Published on by NESIN Awards

Prof. Probal Banerjee | Cancer Biology | Best Researcher Award

Professor| University of New York | United States

Dr. Probal Banerjee is a distinguished Professor of Chemistry and Coordinator of the Center for Developmental Neuroscience at The College of Staten Island, City University of New York, renowned for his pioneering contributions at the intersection of chemistry, neuroscience, and molecular pharmacology. Holding a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore, and postdoctoral training at the University of Notre Dame and the University of Chicago, he has produced over 100 peer-reviewed publications that have advanced understanding of serotonergic signaling in brain development and innovative therapeutic strategies in cancer biology. His groundbreaking research on the 5-HT1A receptor’s role in neonatal hippocampal neurogenesis and on curcumin-based multi-target cancer therapies has redefined approaches to neurodevelopmental and oncological disorders, emphasizing immune modulation and translational impact. Dr. Banerjee’s recent studies on immune-friendly prodrugs and synergistic natural compounds reflect his commitment to safe, mechanism-driven, and sustainable therapeutic innovation. A frequent invited speaker at global scientific forums including Columbia University, NASA Ames, and the Indian Institute of Science, he collaborates internationally to bridge fundamental discovery with clinical relevance. Recognized with multiple honors such as the Brain Research Foundation Award and two Dolphin Awards for academic excellence and teaching, Dr. Banerjee continues to mentor emerging scientists and shape global biomedical research through his visionary work integrating molecular neuroscience, immunology, and drug development to enhance human health worldwide

Profiles: Scopus | ORCID

Featured Publications

Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension. Geroscience. 1 citation (2025).

Targeting sickle cell pathobiology and pain with novel transdermal curcumin. PNAS Nexus. 2 citations (2025).

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Frontiers in Oncology. 2 citations (2019).

Biocompatible anisole-nonlinear PEG core–shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels. 8 citations (2023).

Why don’t the mutant cells that evade DNA repair cause cancer more frequently? Importance of the innate immune system in the tumor microenvironment. International Journal of Molecular Sciences. 4 citations (2023).

The G protein-coupled serotonin 1A receptor augments protein kinase Cε-mediated neurogenesis in neonatal mouse hippocampus—PKCε-mediated signaling in the early hippocampus. International Journal of Molecular Sciences. 2 citations (2022).

Dr. Probal Banerjee’s research bridges chemistry, neuroscience, and immunology to pioneer multi-target therapeutic strategies that combat cancer and neurodevelopmental disorders. His innovative work on curcumin-based immune therapies and serotonergic signaling mechanisms has advanced translational medicine, inspiring new, safer, and globally accessible approaches to human health and disease management.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Published on by NESIN Awards

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Qiushui Wang | Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Qiushui Wang | Molecular Biology | Best Researcher Award

Associate Professor| Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis) | China

Assoc. Prof. Dr. Qiushui Wang (born August 29, 1991) is a distinguished researcher specializing in biochemistry, molecular biology, and microbial natural products, currently serving as an Associate Research Fellow at the Beijing Center for Physical & Chemical Analysis (BCPCA), Beijing Academy of Science and Technology. She earned her Ph.D. in Biochemistry and Molecular Biology from the Institute of Microbiology, Chinese Academy of Sciences (IMCAS) in 2020 under the supervision of Prof. Zhang Lixin, with part of her doctoral research conducted at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) under Prof. Dr. Rolf Müller. Her academic journey began with a Bachelor’s degree in Pharmacy from Shandong University in 2014. Dr. Wang’s research focuses on microbial natural products, CRISPR/Cas9 gene editing in actinomycetes, microbial diversity, and antibiotic resistance mechanisms. She developed the innovative pQS gene-editing system, significantly improving gene-editing efficiency in rare actinomycetes and enabling new insights into the biosynthesis and yield enhancement of key bioactive compounds such as proxmicin and griselimycin. Her current work integrates multi-omics analysis, high-throughput sequencing, and microbial genomics to explore microbial community dynamics, antibiotic resistance genes, and probiotic strain development for aquaculture and crop health. Dr. Wang has authored several influential publications in journals such as Applied Microbiology and Biotechnology, Frontiers in Microbiology, and Environmental Science. Her research skills include microbial genome engineering, bioinformatics, multi-omics data analysis, natural product discovery, and analytical chemistry (HPLC-MS/MS). She has made remarkable contributions to understanding soil–microbe–crop interactions and antibiotic resistance in aquaculture environments. Recognized for her academic excellence and innovative research, Dr. Wang has received multiple institutional honors and continues to contribute significantly to advancing microbial biotechnology and sustainable environmental health. Her interdisciplinary expertise and leadership mark her as a rising figure in biochemical and microbial research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  • Wang, Q., Xie, F., Tong, Y., Habisch, R., Yang, B., Zhang, L., Müller, R., & Fu, C. (2020). Dual-function chromogenic screening-based CRISPR/Cas9 genome editing system for actinomycetes. Applied Microbiology and Biotechnology, 104(1), 225–239. Cited by: 27

  • Xie, F., Dai, S., Zhao, Y., Huang, P., Yu, S., Ren, B., Wang, Q., Ji, Z., Alterovitz, G., … (2020). Generation of fluorinated amychelin siderophores against Pseudomonas aeruginosa infections by a combination of genome mining and mutasynthesis. Cell Chemical Biology, 27(12), 1532–1543.e6. Cited by: 16

  • Fu, C., Xie, F., Hoffmann, J., Wang, Q., Bauer, A., Brönstrup, M., Mahmud, T., … (2019). Armeniaspirol antibiotic biosynthesis: Chlorination and oxidative dechlorination steps affording spiro[4.4]non-8-ene. ChemBioChem, 20(6), 764–769. Cited by: 13

  • Xie, F., Dai, S., Shen, J., Ren, B., Huang, P., Wang, Q., Liu, X., Zhang, B., Dai, H., … (2015). A new salicylate synthase AmS is identified for siderophores biosynthesis in Amycolatopsis methanolica 239T. Applied Microbiology and Biotechnology, 99(14), 5895–5905. Cited by: 10

  • Wang, Q., Zhou, X., Liu, Y., Han, Y., Zuo, J., Deng, J., Yuan, L., Gao, L., & Bai, W. (2023). Mixed oligosaccharides-induced changes in bacterial assembly during cucumber (Cucumis sativus L.) growth. Frontiers in Microbiology, 14, 1195096. Cited by: 9

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by NESIN Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Published on by NESIN Awards

Mr. Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Universidade Federal da Bahia | Brazil

Mr. Valmir Rastely-Junior is a distinguished physician specializing in infectious diseases, pediatrics, and neuropediatrics, with an MD from the Federal University of Bahia (UFBA, 2015). He has accumulated extensive clinical and research experience, focusing on child health, congenital Zika syndrome, antimicrobial resistance, and public health inequities, integrating multidisciplinary care with evidence-based interventions. His professional trajectory includes work at Fiocruz Bahia on neurodevelopmental studies, epidemiologic surveillance, teratogen information services, and COVID-19 teleadvice programs. He has been instrumental in technology-driven initiatives such as Telecoronavírus (UFBA) and Artificial Intelligence as a Service for Combating COVID-19 (Rede CoVida/Cidacs Fiocruz), emphasizing the translation of research into practical, community-focused solutions. Mr. Rastely-Junior’s research interests center on infectious-disease–driven child health, neurodevelopmental outcomes in congenital infections, health disparities, and AI-supported clinical and epidemiological tools. He possesses strong research skills, including clinical study design, epidemiologic analysis, bibliometric synthesis, and international collaborative research, demonstrated through six peer-reviewed publications in Scopus and PubMed-indexed journals, three joint research projects, two conference presentations, and mentorship of research scholars. His work has earned eight awards and recognitions, including first-place honors at Fiocruz Bahia and an honorable mention in the International Balint Award/Ascona Prize, reflecting both scientific excellence and societal impact. Mr. Rastely-Junior is an active member of 16 professional bodies, contributing to editorial, review, and volunteer initiatives that promote knowledge dissemination and community engagement. In conclusion, his blend of clinical expertise, innovative research, international collaborations, and commitment to evidence-based public health positions him as a promising leader in global biomedical research, capable of advancing high-impact publications, AI-enabled solutions, and mentorship programs that enhance healthcare outcomes and scientific standards worldwide. 27 Citations | 3 Documents | 2 h-index.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

  1. Aguilar Ticona, J. P., Nery Jr, N., Doss-Gollin, S., Gambrah, C., Lessa, M., … Rastely-Junior, V. N. (2021). Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLoS One, 16(9), e0256444. https://doi.org/10.1371/journal.pone.0256444. Cited by: 26

  2. Nery Jr, N., Aguilar Ticona, J. P., Gambrah, C., Doss-Gollin, S., Aromolaran, A., … Rastely-Junior, V. N. (2021). Social determinants associated with Zika virus infection in pregnant women. PLoS Neglected Tropical Diseases, 15(7), e0009612. https://doi.org/10.1371/journal.pntd.0009612. Cited by: 14

  3. Aromolaran, A., Araujo, K., Ladines-Lim, J. B., Nery Jr, N., do Rosário, M. S., … Rastely-Junior, V. N. (2022). Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal of Infectious Diseases, 120, 201–204. https://doi.org/10.1016/j.ijid.2022.06.021. Cited by: 6

  4. Mattos, A. M., Rastely-Junior, V. N., Pires, M. M., Aguilar, J. P., Lessa, M. S. A., Regis, C., … (2023). Predictors of neurodevelopment in microcephaly associated with congenital Zika Syndrome: A prospective study. Children, 10(12), 1831. https://doi.org/10.3390/children10121831. Cited by: 3

  5. Brito, L. B., Rastely-Junior, V. N., Browne, E. S., Nery Júnior, N. R. R., … (2016). Sinais e sintomas de zika-virus em gestantes internadas em um Hospital Público de referência da Bahia. Cited by: 2

 

Harpal Buttar | Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Harpal Buttar | Molecular Biology | Best Researcher Award

Adjunct Professor | University of Ottawa | Canada

Prof. Dr. Harpal S. Buttar, D.V.M., M.Sc., Ph.D., FICN, FIACS, FSPER, is an internationally recognized biomedical scientist with expertise in pharmacology, reproductive and developmental toxicology, cardiovascular sciences, and clinical nutrition. He received his Doctor of Veterinary Medicine (D.V.M.) degree from Hissar, India, followed by an M.Sc. and Ph.D. in Pharmacology from the University of Alberta, Canada. With over 41 years of distinguished professional service, he worked as Senior Research Scientist and Assessment Officer at Health Canada, the Canadian counterpart of the US-FDA, while also serving as Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa. His current research focuses on functional foods, nutraceuticals, probiotics, dysbiosis, bioactive components of bovine colostrum, biomarkers of oxidative stress, drug metabolism, Mediterranean diet, and preventive strategies against cardiovascular diseases, obesity, diabetes, and other chronic disorders. He has strong research skills in clinical nutrition, toxicology, drug development, food-drug interactions, and biomedical applications of nanotechnology, with extensive collaborations across Canada, India, Europe, Asia, and the United States. Dr. Buttar has authored 162 peer-reviewed publications, 70 book chapters, and one monograph, with 98 citations from 4 indexed documents and an h-index of 4 (ResearchGate also lists his wider body of work with 4,067 citations and h-index 30). He has been honored with numerous awards, including fellowships from the International College of Nutrition, International Academy of Cardiovascular Sciences, and the Society of Pharmaceutical Education and Research, as well as the Special Recognition Award from the Society for Ethnopharmacology of India. He also has an oration award named after him by IACS India Section in recognition of his global leadership. In conclusion, Dr. Buttar’s outstanding contributions to biomedical sciences, preventive healthcare, and international research collaborations, coupled with his lifelong dedication to mentoring and innovation, make him a highly deserving candidate for prestigious recognition and awards worldwide.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Kumari, A., Singh, S. P., Kumar, P., Yadav, V., & colleagues. (2025, September). A comprehensive review of the epidemiology, pathophysiology, risk factors, and treatment strategies for retinoblastoma.

  2. Wilson, D. W., Gouda, M., De Meester, F., Buttar, H., & colleagues. (2025, June). Nanotherapies for the prevention and treatment of diet- and genetic-related diseases: A systematic review.

  3. Wilson, D. W., Griffiths, K., De Meester, F. M., Sak, K., & colleagues. (2025, June). Polyphenols in plants and impact on human health: Relevance to adaption to global climate change: An overview.

  4. Miran, M., Kamandloo, F., Salami, M., Wilson, D. W., & colleagues. (2025, May). Pathophysiology of diabetes-induced complications: A systematic review concerning the preventive role of dietary polyphenols, probiotics and physical activity.

  5. Gholami, M., Salmani, R. H. G., Madadlou, S. K., Kaur, P., & colleagues. (2025, May). Antidepressant effects of medicinal plants and their pharmacologically active ingredients: A systematic review focused on the serotonergic system.

Pedro Bertemes-Filho | Biomedical Engineering | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Pedro Bertemes-Filho | Biomedical Engineering | Best Researcher Award

Santa Catarina State University, Brazil

Dr. Pedro Bertemes Filho is a distinguished researcher in biomedical engineering, specializing in electrical bioimpedance and medical instrumentation. With a Ph.D. in Medical Physics from the University of Sheffield, he has contributed significantly to biomedical signal processing and the development of wireless clinical devices. His recent focus includes electrical impedance spectroscopy for tissue characterization and cervical cancer diagnosis through large-scale clinical studies in Brazil. As a full professor at UDESC, he leads the Biomedical Engineering research group and teaches across undergraduate to PhD levels. He has held postdoctoral positions at prestigious institutions, including the University of São Paulo and Dartmouth College, and actively collaborates internationally. Dr. Filho serves on editorial boards, is a peer reviewer for leading journals, and holds leadership roles in global bioimpedance societies. His innovative research, academic leadership, and global engagement make him a highly suitable candidate for the Best Researcher Award, recognizing his sustained excellence and impactful contributions.

Professional Profile 

Education🎓

Dr. Pedro Bertemes Filho has an extensive and distinguished academic background in the field of biomedical engineering. He earned his Ph.D. in Medical Physics from the University of Sheffield in the United Kingdom, where he conducted pioneering research in electrical bioimpedance. Prior to his doctoral studies, he completed his undergraduate and master’s degrees in Electrical Engineering in Brazil, laying a strong foundation in electronics and signal processing. Over the years, he has pursued postdoctoral research at renowned institutions such as the University of São Paulo, Brazil, and Dartmouth College, USA, further enhancing his expertise in biomedical instrumentation and clinical applications. His academic journey reflects a deep commitment to interdisciplinary learning and innovation, blending engineering principles with medical sciences. This diverse and robust educational background has equipped him with the knowledge and skills to lead cutting-edge research and mentor students at all academic levels, from undergraduate to doctoral programs, in biomedical engineering.

Professional Experience📝

Dr. Pedro Bertemes Filho has accumulated extensive professional experience in the field of biomedical engineering, marked by academic leadership, innovative research, and international collaboration. He is a full professor at the State University of Santa Catarina (UDESC) in Brazil, where he has played a vital role in advancing research in electrical bioimpedance and biomedical instrumentation. Throughout his career, Dr. Bertemes Filho has led numerous research projects, contributed to scientific development through high-impact publications, and secured funding from national and international agencies. His work includes collaborations with hospitals and universities across Europe, the United States, and Latin America, promoting interdisciplinary applications of biomedical engineering in diagnostics and health monitoring. In addition to research, he has served in various academic leadership roles, including department head and graduate program coordinator, fostering educational excellence and innovation. His professional journey highlights a blend of technical expertise, mentorship, and commitment to improving healthcare through engineering solutions.

Research Interest🔎

Dr. Pedro Bertemes Filho’s research interests lie primarily in the field of biomedical engineering, with a strong focus on electrical bioimpedance, biomedical instrumentation, and the development of non-invasive diagnostic techniques. He is particularly interested in using bioimpedance technology to monitor physiological parameters and detect abnormalities in biological tissues, which has significant implications for early disease diagnosis and patient care. His research also explores the integration of sensors and electronic systems for real-time health monitoring, aiming to improve accessibility and accuracy in clinical settings. Dr. Bertemes Filho is passionate about interdisciplinary approaches, often collaborating with professionals from medicine, physics, and computer science to develop innovative healthcare solutions. His studies are deeply rooted in practical applications, targeting enhancements in diagnostic tools, medical devices, and patient monitoring systems. Through his research, he seeks to bridge the gap between engineering and medicine, ultimately contributing to the advancement of personalized and preventive healthcare technologies.

Award and Honor🏆

Dr. Pedro Bertemes Filho has received numerous awards and honors in recognition of his exceptional contributions to biomedical engineering and academic excellence. He has been acknowledged for his pioneering work in electrical bioimpedance and biomedical instrumentation, which has significantly advanced non-invasive diagnostic techniques. Throughout his career, Dr. Bertemes Filho has earned several research grants and fellowships, both nationally and internationally, underscoring the impact and innovation of his work. He has also been invited as a keynote speaker at prestigious conferences and has served on editorial boards of respected scientific journals, reflecting his leadership in the field. His dedication to teaching and mentoring has been celebrated with academic awards from institutions where he has served, recognizing his commitment to nurturing future scientists and engineers. These accolades not only highlight his scientific achievements but also affirm his role as an influential figure in the global biomedical research community.

Research Skill🔬

Dr. Pedro Bertemes Filho possesses a diverse and robust set of research skills that have significantly advanced the field of biomedical engineering. His expertise lies in electrical bioimpedance, signal processing, and the development of non-invasive diagnostic devices. He is proficient in designing and implementing biomedical instrumentation, integrating both hardware and software components to create innovative solutions for healthcare. Dr. Bertemes Filho is skilled in data acquisition, statistical analysis, and computational modeling, which are essential for validating experimental results and enhancing the accuracy of biomedical systems. He has a strong command of simulation tools and programming languages commonly used in research environments. Additionally, his collaborative approach enables him to work effectively with multidisciplinary teams, fostering innovation across fields such as medicine, electronics, and physics. His ability to translate complex theoretical concepts into practical applications demonstrates his analytical thinking, problem-solving capacity, and commitment to advancing scientific knowledge for real-world impact.

Publications Top Noted✍️

  • Title: A comparison of modified Howland circuits as current generators with current mirror type circuits
    Authors: P. Bertemes-Filho, B.H. Brown, A.J. Wilson
    Year: 2000
    Citations: 130

  • Title: Bipolar and tetrapolar transfer impedance measurements from volume conductor
    Authors: B.H. Brown, A.J. Wilson, P. Bertemes-Filho
    Year: 2000
    Citations: 102

  • Title: Bioimpedance in biomedical applications and research
    Authors: F. Simini, P. Bertemes-Filho
    Year: 2018
    Citations: 83

  • Title: High accurate Howland current source: Output constraints analysis
    Authors: P. Bertemes-Filho, A. Felipe, V.C. Vincence
    Year: 2013
    Citations: 77

  • Title: Tissue characterisation using an impedance spectroscopy probe
    Author: P. Bertemes-Filho
    Year: 2002
    Citations: 75

  • Title: Comparison of three current sources for single-electrode capacitance measurement
    Authors: D.X. Chen, X. Deng, W.Q. Yang
    Year: 2010
    Citations: 51

  • Title: Analytical model for blood glucose detection using electrical impedance spectroscopy
    Authors: B.G. Pedro, D.W.C. Marcôndes, P. Bertemes-Filho
    Year: 2020
    Citations: 45

  • Title: Biomedical serious game system for lower limb motor rehabilitation of hemiparetic stroke patients
    Authors: F. Noveletto, A.V. Soares, F.L.F. Eichinger, S.C. Domenech, M.S. Hounsell, et al.
    Year: 2020
    Citations: 40

  • Title: Biomedical serious game system for balance rehabilitation of hemiparetic stroke patients
    Authors: F. Noveletto, A.V. Soares, B.A. Mello, C.N. Sevegnani, F.L.F. Eichinger, et al.
    Year: 2018
    Citations: 39

  • Title: Howland current source for high impedance load applications
    Authors: K.F. Morcelles, V.G. Sirtoli, P. Bertemes-Filho, V.C. Vincence
    Year: 2017
    Citations: 37

  • Title: Low power current sources for bioimpedance measurements: A comparison between Howland and integrated CMOS OTA circuits
    Authors: P. Bertemes-Filho, V.C. Vincence, M.S. Santos, I.X. Zanatta
    Year: 2012
    Citations: 35

  • Title: Mirrored modified Howland circuit for bioimpedance applications: analytical analysis
    Authors: P. Bertemes-Filho, L.H. Negri, A. Felipe, V.C. Vincence
    Year: 2012
    Citations: 32

  • Title: Bioelectrical impedance analysis for bovine milk: preliminary results
    Authors: P. Bertemes-Filho, R. Valicheski, R.M. Pereira, A.S. Paterno
    Year: 2010
    Citations: 28

  • Title: Analog front-end for the integrated circuit AD5933 used in electrical bioimpedance measurements
    Authors: F. Noveletto, P. Bertemes-Filho, D. Dutra
    Year: 2016
    Citations: 26

  • Title: Gelatin: A skin phantom for bioimpedance spectroscopy
    Authors: A.M.R. Pinto, P. Bertemes-Filho, A. Paterno
    Year: 2015
    Citations: 24

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Published on by NESIN Awards

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short